jp's domain

The report, prepared for the European medicines authority following withdrawal of the drug in June, is a fresh embarrassment for Roche, which produced the medicine in its factory in Basel. At a time of heightened international concern over counterfeit and substandard medicines, the details of the inquiry suggest flaws in manufacturing even by one of the world's largest pharmaceutical groups. Roche was forced to withdraw Viracept in co ordination with regulators, after reports from patients of a "strange smell" with the drug, and one incident of nausea and vomiting. Viracept, a second line HIV therapy called a protease inhibitor, is not widely used in developed countries and accounted for only SFr164m ($149m) of Roche's SFr42bn sales last year. However, the recall triggered concern in developing countries where it is more frequently prescribed and where the systems for contacting patients and doctors to warn them and provide...
http://bestnews-4u.com/

last updated 1 year ago #